2018 August 29 - IDSA News

Read the last issue of IDSA News

Read the next issue of IDSA News

IDSA Honors 105 Distinguished Physicians, Scientists with FIDSA

IDSA congratulates the distinguished physicians and scientists from the United States and around the world who were elected this year to be Fellows of IDSA.

Journal Club

In this feature, a panel of IDSA members identifies and critiques important new studies in the current literature that have a significant impact on the practice of infectious diseases medicine.
Reviews in this issue: Late Pregnancy and Postpartum: The Highest Risk Period for HIV Acquisition, Removing Gloves as a Requirement for Contact Precautions, and Hepatitis A Vaccine Effective in HIV+ Individuals During an Outbreak, But with Slower Seroconversion

Protecting ID Laboratory Developed Tests

IDSA continues to educate policymakers about the important role of laboratory developed tests (LDTs) in ID patient care and public health and to share our concerns about proposals from Congress and the Food and Drug Administration (FDA) to impose burdensome regulations on the development and use of LDTs that could seriously jeopardize patient access to high quality testing.

The IDSA Foundation Honors Leading Women

Through its first annual Women of ID campaign, the IDSA Foundation honored four phenomenal women who have made a profound impact on our everyday lives by transforming the field of infectious diseases.

IDSA Co-Sponsors CDC Congressional Study Tour

IDSA joined the American Society of Tropical Medicine and Hygiene, the Global Health Council, PATH, and the Global Health Technologies Coalition to sponsor a congressional staff study tour of the CDC’s Center for Global Health in Atlanta, Ga. in August.

Members Advocating for ID: In-Person Meetings Tell the Story of ID

“Accounts of young addicts presenting with strokes from endocarditis put a human face on the [opioid] problem,” shared IDSA member Marcia Epstein, MD, FIDSA following her meeting with aides to Senators Chuck Schumer and Kirsten Gillibrand of New York. Dr. Epstein noted the impact of emphasizing patient stories over statistics.

Science Speaks Spotlights Innovations on the Ground

IDSA’s Science Speaks blog discussed life-saving impacts of early infant point-of-care HIV testing, to the hope offered by an investigational Ebola vaccine and the reprieve offered by new TB medicines, and gains propelled by biomedical research.

National Media Turn to IDSA Members for Information, Expertise

HuffPost, Chicago Tribune, Forbes, The Hill: In just the past two weeks, IDSA spokespersons have interviewed with these media organizations and more, providing facts, perspectives and important public health information about infectious diseases to the public.

ICYMI: What’s Hot on MyIDSA

Keep up with the latest information on the MyIDSA community boards.